Grants and Contributions:
Title:
Generative AI for RNA Reprogramming and Therapeutics
Agreement Number:
1041757
Agreement Value:
$75,000.00
Agreement Date:
May 1, 2026 - Mar 31, 2027
Description:
RNARevive intends to develop and validate a generative AI platform to improve the design of self-amplifying RNA therapeutics. The project will integrate proprietary and public sequence-outcome data to predict RNA stability, immunogenicity, and replication efficiency, and to prioritize the most promising candidates for experimental validation. The goal is to reduce construct attrition, shorten development timelines, and improve the success rate of RNA therapeutic programs.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Edmonton, Alberta, CA T5J 0B2
Reference Number:
172-2026-2027-Q1-1041757
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
729033621
Recipient Type:
For-profit organization
Recipient's Operating Name:
RNARevive
Recipient's Legal Name:
2673189 Alberta Inc
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710